| 251 |
14703068 | Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer. | 2003 Dec |
3 |
| 252 |
14715110 | Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results. | 2003 Dec |
1 |
| 253 |
11872346 | C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. | 2002 Mar |
1 |
| 254 |
11919237 | Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. | 2002 Apr 1 |
3 |
| 255 |
12108894 | The current status of docetaxel for metastatic breast cancer. | 2002 Jun |
2 |
| 256 |
12173324 | HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial. | 2002 May 15 |
2 |
| 257 |
12419746 | In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines. | 2002 Nov |
1 |
| 258 |
12435858 | Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. | 2002 Aug |
1 |
| 259 |
11521725 | Ongoing trials with trastuzumab in metastatic breast cancer. | 2001 |
1 |
| 260 |
11685733 | Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer. | 2001 Aug |
1 |
| 261 |
11694787 | Interaction between Herceptin and taxanes. | 2001 |
1 |
| 262 |
11899413 | Platinum compounds in the treatment of advanced breast cancer. | 2001 Oct |
1 |
| 263 |
10699953 | Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. | 2000 Mar 1 |
2 |
| 264 |
10810934 | Docetaxel (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin). | 2000 Apr |
2 |
| 265 |
11778270 | [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity]. | 2000 Sep |
4 |
| 266 |
9572489 | Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. | 1998 Apr 23 |
2 |
| 267 |
9285690 | Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A. | 1997 Aug 18 |
2 |